A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure
Sponsor: Triomed AB
Terminated
After 2 patients it was concluded that a large change in exclusion criteria and study design was needed to obtain the ojective for the study
Other Cardio-Renal Syndrome trials with similar outcome
Listed as NCT02772146, this NA trial focuses on Cardio-Renal Syndrome and Heart Failure and remains terminated or withdrawn. Sponsored by Triomed AB, it has been updated 10 times since 2016, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated NA
-
May 2018 — Jun 2018 [monthly]
Terminated NA
-
Aug 2017 — May 2018 [monthly]
Terminated NA
-
Apr 2017 — Aug 2017 [monthly]
Terminated NA
Status: Enrolling By Invitation → Terminated
-
Jan 2017 — Apr 2017 [monthly]
Enrolling By Invitation NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Triomed AB
For direct contact, visit the study record on ClinicalTrials.gov .